Li X, Chen Y, Bai L, Zhao R, et al. Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models. Br J Cancer 2023 Jul 20. doi: 10.1038/s41416-023-02359.
PMID: 37474721